pentoxifylline has been researched along with Leishmaniasis, Visceral in 1 studies
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gangneux, JP | 1 |
| Chau, F | 1 |
| Sulahian, A | 1 |
| Derouin, F | 1 |
| Garin, YJ | 1 |
1 other study available for pentoxifylline and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis.
Topics: Acute Disease; Animals; Dexamethasone; Female; Hydrocortisone; Immunophenotyping; Immunosuppressive | 1999 |